The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival impact of EGFR TKI on patients with lepidic brochioalveolar metastatic non-small cell lung cancer (NSCLC).
Marie-Eve Gagnon
No relevant relationships to disclose
Normand Blais
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Mustapha Ali Tehfe
No relevant relationships to disclose
Marie Florescu
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche